US Stock MarketDetailed Quotes

BCYC Bicycle Therapeutics

Watchlist
  • 15.315
  • +0.175+1.16%
Close Dec 18 16:00 ET
  • 15.360
  • +0.045+0.29%
Pre 08:00 ET
1.06BMarket Cap-4.67P/E (TTM)

Bicycle Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bicycle Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.260M--
--2024/Q4-- / 5.341M--
--2024/Q32.676M / 7.005M--
--2024/Q29.361M / 6.283M--
--2024/Q119.530M / 6.066M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.260M--
--2024/Q4-- / 5.341M--
--2024/Q32.676M / 7.005M--
--2024/Q29.361M / 6.283M--
--2024/Q119.530M / 6.066M--

Unlock Free Earnings Estimates

Bicycle Therapeutics Earnings Reports

  • Bicycle Therapeutics | 10-Q: Q3 2024 Earnings Report

    Oct 31 07:25 ET

  • Bicycle Therapeutics | 8-K: Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results

    Oct 31 07:10 ET

  • Bicycle Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 07:43 ET

  • Bicycle Therapeutics | 8-K: Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results

    Aug 6 07:08 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Dorian LPG
    LPG
    +1.66%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    0.00%
    AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
    AIPUY
    0.00%
    eBay
    EBAY
    -0.19%
    Lantheus
    LNTH
    -1.63%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 19, 2024

    Buy

    • Buy

      72.73%

    • Hold

      27.27%

    • Sell

      0.00%

    Price Target

    No Data